BMO Capital analyst, Gary Nachman, reiterated his Outperform rating on shares of Optinose (NASDAQ: OPTN) after the company provided updated ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE